Nabila Nora (Baiti) Bennani MD

PubMed

• 15 citations
  Don't Put the CART Before the Horse: The Role of Radiation Therapy in Peri-CAR T-cell Therapy for Aggressive B-cell Non-Hodgkin Lymphoma.
  Omran Saifi, William G Breen, Scott C Lester, William G Rule, Bradley J Stish
  International Journal of Radiation Oncology, Biology, Physics. 2023-08-01
• 2 citations
  Sirolimus as frontline therapy for-mutated histiocytic sarcoma.
  Karan L Chohan, Jithma P Abeykoon, Jason R Young, W Oliver Tobin, Mathew J Koster
  Haematologica. 2023-06-01
• 15 citations
  Procalcitonin as a biomarker for predicting bacterial infection in chimeric antigen receptor T-cell therapy recipients.
  Marissa Z Powell, Kristin C Mara, Radhika Bansal, Matthew A Hathcock, Arushi Khurana
  Cancer Medicine. 2023-04-01

Journal Articles

• Genetic Subtyping of Breast Implant-Associated Anaplastic Large Cell Lymphoma  
  Andrew L Feldman, Garry S Brody, Rhett P Ketterling, N Nora Bennani, Mark W Clemens, Ellen D McPhail, Christin A Harless, David S Viswanatha, Rong He, Blood

Abstracts/Posters

• Characteristics, Treatment Patterns, and Outcomes in Primary Cutaneous Gamma Delta T Cell Lymphoma (PCGDTCL): A Real World Multi-Institutional Analysis of a Rare Malig...
  N. Nora Bennani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Peak Lymphocyte Count after CAR T Infusion Is a Clinically Accessible Test That Correlates with Clinical Response in Axicabtagene Ciloleucel Therapy for Lymphoma
  N. Nora Bennani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Single-Agent Cladribine As an Effective Therapy for Adults with Langerhans Cell Histiocytosis
  Nora N Bennani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Molecular Alterations in Adult Histiocytic Neoplasms
  Nora N Bennani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Clinical Features and Outcomes of Unifocal Adult Langerhans Cell Histiocytosis
  N. Nora Bennani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Patient Experience of Chimeric Antigen Receptor (CAR)-T Cell Therapy Vs. Stem Cell Transplant: Longitudinal Patient Reported Adverse Events, Cognition and Quality of Life
  N. Nora Bennani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Fitness and Anthracycline Use in Front-Line Therapy for Older Patients with Classical Hodgkin Lymphoma: A US Multi-Center Retrospective Analysis
  N. Nora Bennani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Characteristics and Outcomes of Patients Who Did Not Develop CRS after Axicabtagene Ciloleucel for Relapsed/Refractory Large B-Cell Lymphoma: Results from the US Lymph...
  N. Nora Bennani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Characteristics and Outcomes of Patients Who Did Not Develop CRS after Axicabtagene Ciloleucel for Relapsed/Refractory Large B-Cell Lymphoma: Results from the US Lymph...
  N. Nora Bennani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• ZUMA-11: A Phase 1/2 Multicenter Study of Axicabtagene Ciloleucel (Axi-Cel) + Utomilumab Patients with Refractory Large B Cell Lymphoma
  Nabila N. Bennani, 61st Annual American Society of Hematology Meeting, 61st Annual American Society of Hematology Meeting - Orlando, FL, 12/9/2019
• Join now to see all

Lectures

• Copanlisib in Combination with Nivolumab in Subjects with Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Primary Mediastinal Large B-Cell Lymphoma: A Phase 2 Study 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Axicabtagene Ciloleucel (Axi-cel) CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma: Real World ExperienceClinically Re... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Tumor Mutational Burden and Other Immunotherapy Markers in Histiocytic Neoplasms Using Next Generation Sequencing 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018